Self-transporter used for homologous recombination, and mucosal immune vaccine constructed thereby
A technology of homologous recombination and autotransporter, applied in the field of cervical cancer preventive vaccines, can solve problems such as the stability of foreign genes and the safety of carriers.
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment Construction
[0037] The present invention will be further described in detail below in conjunction with specific embodiments, which are explanations of the present invention rather than limitations.
[0038] 1. Selection of autotransporter IcsA
[0039] IcsA is an outer membrane protein with a molecular weight of 120kD, encoded in a virulent plasmid of 220kb, and is the most important factor promoting intercellular transmission of Shigella. As a member of the outer membrane protein autotransport family, IcsA can mediate its own transmembrane and surface presented. Similar to other autotransporters, IcsA has three structural and functional domains: the amino-terminal 52 amino acids (IcsA 1-52) is a signal peptide that mediates the transport of the entire protein across the bacterial inner membrane through the Sec system; the next α domain (Ics 53-757 ) is the main functional domain of the protein. When presented on the surface of the non-dividing segment of bacteria, it can recruit actin ...
PUM
Login to View More Abstract
Description
Claims
Application Information
Login to View More 